We dedicate @iScience_CP paper on #apoptosis initiation with BAK activators to Dr. Geetika Singh @GeetikaGitika2, who recently lost her life to cancer. We are humbled by this tragedy and grateful for life and important contributions at many levels.
doi:10.1016/j.isci.2022.105064
Explore original research oncology professionals and scientists from St. Jude will present throughout the American Society of Clinical Oncology’s annual meeting June 3-7 in Chicago. https://t.co/T8NeaYU5Qd @ASCO#ASCO22
New computational method from our lab in @NAR_Open showing that cell type identification in spatial transcriptomics data can be improved using paired tissue images - we show interesting use cases using immunofluorescence data and AI annotated H&E images: https://t.co/4mZTkVeDPP
Read about what my colleagues are doing in the Neurobiology and Brain Tumor Program to develop treatments for pediatric brain tumors that are more effective and with less side effects.
#BrainTumorAwarenessMonth
Research and clinical developments over the past decades have made treatment for childhood brain tumors more effective and with fewer side effects. Learn about how research at St. Jude has shaped the future of brain tumor care. https://t.co/A9G1l6cKaO #BTAM
.@GiedreKrenciute will give a primer on “Gene Editing to Improve CAR-T Cell Therapy” during the Immune Effector Cell Therapies workshop Sunday, May 15, 2:50 pm ET at #ASGCT22. https://t.co/BDfITuQyRc
The basic and translational research lab of Dr. Stephen Mack is digging into the metabolic and epigenetic programs in cancer to find ways to treat brain tumors. https://t.co/i21QPvvx79 #DIPG@emacalate
5 years and counting! I feel incredibly fortunate to work with world-renowned scientists and clinicians everyday to improve survival and reduce morbidity in children with cancer. I look forward to more scientific breakthroughs in the years to come! #ILoveStJude
2021 is the 25th anniversary of St. Jude emeritus faculty member @ProfPCDoherty’s @NobelPrize in Physiology or Medicine w/Dr. Rolf Zinkernagel. Of the science, Doherty said “It was a revolutionary concept, something people hadn’t expected.” https://t.co/BESplOG3SD #NobelPrizeDay
Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @CD_AACR paper. https://t.co/PLlklVzrD6 @ADurbinLab
Dr. Suzanne Baker introduces the 2020 and 2021 MSc candidates in Biomedical Sciences. Congratulations to all of the graduating students! #stjudegradschool
Thanks to donors like you, St. Jude embarks on the next era of scientific discovery with the Inspiration4 Advanced Research Center. The 625,000 square-foot facility currently has 64 labs working to accelerate the pace of discovery for childhood cancer and other diseases.
Scientists have shown it is possible to assess measurable residual disease in medulloblastoma liquid biopsies. Read the @Cancer_Cell paper. https://t.co/aZpJJHcDX9 @drpaulnorthcott @DrGilesRobinson#childhoodcancer
Congratulations to Dr. Jennifer Stripay on being named one of @MBJMemphis Health Care Heroes for work as a scientific writer. https://t.co/6AkuDi9GkC #SciComm
Pain during childhood leukemia therapy may increase risk for neurocognitive late effects. Evidence-based behavioral interventions should be included in pain management. Learn more. https://t.co/3emTbTS0Qu
@PAINthejournal@drlisajacola
The last 10 years have seen big strides in pediatric immune-oncology—the topic of the 2021 St. Jude Biomedical Symposium. It brought together immuno-oncology and cell therapy experts to discuss the field’s discoveries and challenges. @Kyttaro_Therapy@doctorbish@PGTimmune
.@DavidMuir reports on the patients from St. Jude Children’s Hospital who asked the all-civilian crew of Inspiration4 a few long-distance questions about their historic space flight. https://t.co/kgpjRaHUiz